Use of ChatGPT in Developing Health Materials on 'Immunization' for Nursing Students

March 25, 2025 updated by: DİLAY NECİPOĞLU, Near East University, Turkey

Use of ChatGPT in Developing Health Materials on 'Immunization' for Nursing Students; A Randomized Controlled Trial

Purpose: This study aims to determine the effect of using ChatGPT, an artificial intelligence program, on the development of health materials on immunization by senior nursing students. Materials and Methods: This study was conducted as a randomized controlled trial. The universe of the study consists of N=156 senior nursing students. However, 16 students who did not participate in the study were excluded from the study. The students filled out the 'Introductory Data Form' and 'Consent' form. Then, a faculty member other than the researchers completed the assignment of the students to the groups using the simple randomization technique (randomizer.org website) and forwarded the results to one of the researchers (DN) using the sealed envelope method. The study was completed with 63 students in the intervention group and n=77 students in the control group. Within the scope of a course taken by the students, the subject of 'immunization' was explained to the class as a theoretical lesson through traditional narration. The students were given the task of designing educational materials on the subject explained. One of the researchers (DN) made an appointment with the group of students assigned to the intervention group, arranged a meeting and provided 1-hour consultancy on the use of ChatGPT. Students were asked to conduct a search on ChatGPT using 3 keywords: 'nursing, health material and immunization'. On the specified date and time, students in the intervention and control groups were gathered in the classroom and introduced the health materials, students designed in the classroom. The health materials were evaluated by the researcher (KE) in the classroom using data collection forms ('Evaluation Form of Visual Design Principles and Elements' and 'Global Quality Scale'). The research was conducted in 3 moths. The data were evaluated using the SPSS 25.0 package program. In order to conduct the research, ethics committee permission, institutional permission, scale permission and written consents were obtained from the participants.

Study Overview

Status

Completed

Conditions

Detailed Description

Artificial intelligence is an innovative approach to simulation of human intelligence consisting of algorithms. Samoili defined artificial intelligence as "software (and possibly also hardware) systems designed by humans that, given a complex goal, act in the physical or digital dimension by perceiving their environment through data acquisition, interpreting the collected structured or unstructured data, reasoning on the knowledge, or processing the information, derived from this data and deciding the best action(s) to take to achieve the given goal. AI systems can either use symbolic rules or learn a numeric model, and they can also adapt their behavior by analyzing how the environment is affected by their previous actions". Artificial intelligence tries to imitate human cognitive abilities such as abstract reasoning, knowledge representation, learning, autonomous decision-making, communicating in natural languages, perceiving and interacting with the natural world. Today, artificial intelligence is widely used in many fields. Especially in the field of health, the use of artificial intelligence is becoming increasingly widespread in the field of nursing. In a century where technology is rapidly advancing in the world, artificial intelligence applications represent a largely new era in nursing practice.

This study aims to determine the effect of using ChatGPT, an artificial intelligence program, on the development of health materials on immunization by senior nursing students. Materials and Methods: This study was conducted as a randomized controlled trial. The universe of the study consists of N=156 senior nursing students. However, 16 students who did not participate in the study were excluded from the study. The students filled out the 'Introductory Data Form' and 'Consent' form. Then, a faculty member other than the researchers completed the assignment of the students to the groups using the simple randomization technique (randomizer.org website) and forwarded the results to one of the researchers (DN) using the sealed envelope method. The study was completed with 63 students in the intervention group and n=77 students in the control group. Within the scope of a course taken by the students, the subject of 'immunization' was explained to the class as a theoretical lesson through traditional narration. The students were given the task of designing educational materials on the subject explained. One of the researchers (DN) made an appointment with the group of students assigned to the intervention group, arranged a meeting and provided 1-hour consultancy on the use of ChatGPT. Students were asked to conduct a search on ChatGPT using 3 keywords: 'nursing, health material and immunization'. On the specified date and time, students in the intervention and control groups were gathered in the classroom and introduced the health materials, students designed in the classroom. The health materials were evaluated by the researcher (KE) in the classroom using data collection forms ('Evaluation Form of Visual Design Principles and Elements' and 'Global Quality Scale'). The research was conducted in 3 months. The data were evaluated using the SPSS 25.0 package program. In order to conduct the research, ethics committee permission, institutional permission, scale permission and written consents were obtained from the participants.

Inclusion criteria:

  • Volunteering to participate in the study
  • Being in the final year of the Turkish nursing department
  • Participating in the Evidence-Based Nursing Practices course

Exclusion criteria: Having previously prepared health materials using an artificial intelligence program

Research variables While the independent variables of the study were the adolescent's introductory data, the dependent variable was the average scores participants received from the 'Evaluation Form of Visual Design Principles and Elements' scale and the 'Global Quality Scale'.

Data evaluation: SPSS 25.0 package program was used in statistical analyses. Percentage and frequency tests were applied in the evaluation of the data. The Kolmogorov-Smirnov Test was used to evaluate the data's compliance with normal distribution. Independent t Test was used for data that conformed to normal distribution. Data were evaluated with a 95% confidence interval and a p-value of 0.05 margin of error.

Study Type

Interventional

Enrollment (Actual)

140

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nicosia, Cyprus
        • Near East University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Volunteering to participate in the study

  • Being in the final year of the Turkish nursing department
  • Attending the Evidence-Based Nursing Practices course

Exclusion Criteria:

  • Having previously prepared health materials using an artificial intelligence program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
With the start of the use of artificial intelligence in the field of nursing, we are trying to increase the skills of students by providing them with training in this field.
No Intervention: Control Group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Visual Design Principles and Elements Evaluation Form
Time Frame: 2025
The Visual Design Principles and Elements Evaluation Form was developed by Yalın in 2003 in a 3-point Likert type. The measurement tool consists of 19 items. It has 3 sub-dimensions. These dimensions are named as "appropriate use of design elements", "correct use of design principles" and "structural features" respectively. There are 19 items in the form, 10 in the "appropriate use of design elements" dimension, 6 in the "correct use of design principles" dimension and 3 in the "structural features" dimension. The form is a Likert type form with three categories as "very good", "acceptable" and "weak".
2025

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 25, 2024

Primary Completion (Actual)

February 20, 2025

Study Completion (Actual)

February 20, 2025

Study Registration Dates

First Submitted

March 13, 2025

First Submitted That Met QC Criteria

March 19, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 30, 2025

Last Update Submitted That Met QC Criteria

March 25, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Near East Universty

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data sharing can be done on a confidential basis upon request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nursing Education

Clinical Trials on artifial intelligence education

Subscribe